Boiron : Projet d’Offre Publique d’Achat à 50 € avec dividende exceptionnel fixé à 10,36 € : le prix nous paraît bas
>Rachat de la famille à 50 € avec EW Healthcare Partners - Après suspension du titre hier, Boiron a communiqué hier sur un projet d’OPA simplifié avec intention de retirer la société du marché boursier, sur la base d’un prix d’offre de 50 €, correspondant au dernier cours + un dividende exceptionnel de 10,36 €.La famille, via Boiron Développement, et EW Heathcare Partners (ex.Essex Woodlnads, fonds de PE basé aux USA) et éventuellement les salariés du groupe (FCP...Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.